Cantel Medical Corp (CMN) has reported a 24.91 percent rise in profit for the quarter ended Apr. 30, 2017. The company has earned $17.51 million, or $0.42 a share in the quarter, compared with $14.02 million, or $0.34 a share for the same period last year. On the other hand, adjusted net income for the quarter stood at $21.38 million, or $0.51 a share compared with $18.24 million or $0.44 a share, a year ago.
Revenue during the quarter grew 10.60 percent to $192.11 million from $173.70 million in the previous year period. Gross margin for the quarter expanded 136 basis points over the previous year period to 47.60 percent. Total expenses were 85.71 percent of quarterly revenues, down from 86.61 percent for the same period last year. This has led to an improvement of 89 basis points in operating margin to 14.29 percent.
Operating income for the quarter was $27.44 million, compared with $23.26 million in the previous year period.
However, the adjusted EBITDA for the quarter stood at $38.81 million compared with $34.82 million in the prior year period. At the same time, adjusted EBITDA margin improved 16 basis points in the quarter to 20.20 percent from 20.05 percent in the last year period.
Jorgen B. Hansen, Cantel's president and chief executive officer stated, "We are pleased to report very solid sales growth and earnings performance this quarter. Our 10.6% reported sales growth was driven by organic growth of 7.4%, acquisitions contributed 4.4% and foreign currency impact of (1.2%). We saw record performance internationally, where sales were up 18.1% overall, with strong underlying organic growth. Gross margin expanded 140 basis points to 47.6% driven by a strategic focus on driving favorable product mix as well as our strong execution of our continuous improvement efforts."
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: editor@irisindia.net